Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Other Non-Current Assets (2016 - 2025)

Historic Other Non-Current Assets for Cumberland Pharmaceuticals (CPIX) over the last 17 years, with Q3 2025 value amounting to $3.0 million.

  • Cumberland Pharmaceuticals' Other Non-Current Assets rose 555.3% to $3.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.0 million, marking a year-over-year increase of 555.3%. This contributed to the annual value of $2.8 million for FY2024, which is 338.28% up from last year.
  • Per Cumberland Pharmaceuticals' latest filing, its Other Non-Current Assets stood at $3.0 million for Q3 2025, which was up 555.3% from $2.9 million recorded in Q2 2025.
  • Cumberland Pharmaceuticals' 5-year Other Non-Current Assets high stood at $3.5 million for Q2 2021, and its period low was $2.4 million during Q3 2022.
  • In the last 5 years, Cumberland Pharmaceuticals' Other Non-Current Assets had a median value of $2.8 million in 2024 and averaged $2.9 million.
  • Its Other Non-Current Assets has fluctuated over the past 5 years, first skyrocketed by 3144.73% in 2021, then crashed by 2733.69% in 2022.
  • Over the past 5 years, Cumberland Pharmaceuticals' Other Non-Current Assets (Quarter) stood at $3.4 million in 2021, then fell by 26.29% to $2.5 million in 2022, then grew by 6.83% to $2.7 million in 2023, then grew by 3.38% to $2.8 million in 2024, then grew by 7.28% to $3.0 million in 2025.
  • Its last three reported values are $3.0 million in Q3 2025, $2.9 million for Q2 2025, and $2.7 million during Q1 2025.